Details of the Drug

General Information of Drug (ID: DMDUGIQ)

• Drug Name: Longeveron Mesenchymal Stem Cells
• Synonyms: LMSC

Indication

Disease Entry	ICD 11	Status	REF
Frailty	MG2A	Phase 1/2	[1]
Hypoplastic left heart syndrome	LA89.3	Phase 1/2	[2]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DMK65T
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT02982915) Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty (HERA). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT03525418) Longeveron Mesenchymal Stem Cells (LMSCs) Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) (ELPIS). U.S. National Institutes of Health.